Literature DB >> 12093494

Determination and degradation study of haloperidol by high performance liquid chromatography.

H Trabelsi1, S Bouabdallah, K Bouzouita, F Safta.   

Abstract

A specific, high performance liquid chromatographic method was developed for the assay of haloperidol, together with an adequate separation of its degradation products. The method is based on the use of an octadecylsilane stationary phase column under isocratic conditions. The mobile phase consisted of 50 mM sodium phosphate monobasic pH 2.5-acetonitrile-THF-TEA (63:34:3:0.1, v/v/v/v) adjusted with o-phosphoric acid to a pH of 2.5. The degradation was performed in hydrochloric acid, sodium hydroxide and hydrogen peroxide. The main degradation products were identified. Application of the assay of haloperidol in tablet formulations is presented.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093494     DOI: 10.1016/s0731-7085(02)00104-8

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Visualization and Non-Destructive Quantification of Inkjet-Printed Pharmaceuticals on Different Substrates Using Raman Spectroscopy and Raman Chemical Imaging.

Authors:  Magnus Edinger; Daniel Bar-Shalom; Jukka Rantanen; Natalja Genina
Journal:  Pharm Res       Date:  2017-03-01       Impact factor: 4.200

2.  Simultaneous RP-HPLC-DAD quantification of bromocriptine, haloperidol and its diazepane structural analog in rat plasma with droperidol as internal standard for application to drug-interaction pharmacokinetics.

Authors:  Johnique Billups; Cynthia Jones; Tanise L Jackson; Seth Y Ablordeppey; Shawn D Spencer
Journal:  Biomed Chromatogr       Date:  2010-07       Impact factor: 1.902

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.